Leadership

Dr. Oliver Marseille,  CEO & CTO
Dr. Oliver Marseille, CEO & CTO

Dr. Oliver Marseille, CEO & CTO, is an entrepreneur and inventor with over 25 years of experience in cardiovascular device development with numerous CE and FDA approvals. He holds a degree in mechanical engineering (MSc) and received his Ph.D. from Helmholtz Institute in Aachen, Germany. He was co-founder and managing Director of CircuLite GmbH, where he directed the development and regulatory approval of the smallest implantable VAD system. Previous positions include head of R&D at Medos AG.

HEMOVENT PRODUCTS ARE NOT CLEARED OR APPROVED BY THE
U.S. FOOD AND DRUG ADMINISTRATION AND ARE NOT AVAILABLE FOR SALE IN THE U.S.